Nanomedicine News

RSS

Chemists Witness Atoms of One Chemical Element Morph Into Another

Chemists at Tufts University’s School of Arts and Sciences, collaborating with PerkinElmer and UCL (University College London), have witnessed atoms of one chemical element morph into another for the first time ever—a feat that produced an unexpected outcome that could lead to a new way to safely treat cancer with radiation.

17 Jun 2015

Viscosizer TD from Malvern Instruments: A New Automated Tool for Biophysical Characterization

Malvern Panalytical has launched a new system based around Taylor Dispersion Analysis (TDA) to provide researchers with a novel orthogonal technique to accelerate biopharmaceutical drug candidates through the development pipeline.

From Malvern Panalytical 16 Jun 2015

Novel Nanoplatform Technology to Detect Cancer Cells and Tumors in Early Stages

A U.S. patent has been awarded to a Kansas State University technology that quickly detects the early stages of cancer before physical symptoms ever appear.

16 Jun 2015

Scientists Successfully Characterize Molecular Structure of Small Heat Shock Protein

Small heat shock proteins ensure that other proteins do not clot, allowing the cell to survive stress. Defects in these "small helpers" are associated with medical conditions like cataracts and cancer. Now, scientists at the Technische Universität München (TUM) have characterized a small heat shock protein responsible for embryonic development in the Caenorhabditis elegans nematode. Presumably, a similar protein exists also in humans.

12 Jun 2015

TechConnect 2015: Lehigh to Present Nanoscale Device to Capture Tumor Cells

Lehigh University engineers, materials scientists and chemists will present their innovative breakthroughs to a national showcase of investors and industrial partners at the TechConnect 2015 World Innovation Conference and National Innovation Showcase in Washington on June 14-17.

12 Jun 2015

Trojan Horse Nanoparticles Release Payload to Turn Off XBP1 Gene to Treat Ovarian Tumors

Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, Weill Cornell Medical College scientists report today. But a therapy that restores the cells' disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.

12 Jun 2015

BIND and Macrophage Therapeutics Collaborate to Engineer Accurins with Manocept Targeting Platform

BIND Therapeutics, Inc., a clinical-stage nanomedicine company developing targeted and programmable therapeutics called Accurins™, and Macrophage Therapeutics, a subsidiary of Navidea Biopharmaceuticals, Inc. today announced they have entered into a research collaboration to engineer Accurins with the Manocept™ targeting platform that enables selective, efficient binding to CD206 positive disease-associated macrophages.

12 Jun 2015

Arcturus, Janssen Collaborate to Commercialize RNA-Based Drugs Using Nanoparticle Delivery Platform

Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals, Inc. (Janssen). Under the agreement, facilitated by J&J Innovation, the parties will work together to develop and commercialize RNA-based drug products for the treatment of specified diseases using Arcturus' UNA Oligomer™ chemistry and LUNAR™ nanoparticle delivery platform.

12 Jun 2015

Merrimack Expands Phase 1 Study of Iron Oxide Nanoparticle Marker for nal-IRI Tumor Response Prediction

Merrimack Pharmaceuticals, Inc. today announced the initiation of clinical imaging assessing the use of a potential marker for delivery of MM-398 (irinotecan liposome injection), also known as "nal-IRI," to metastatic breast cancer.

12 Jun 2015

Battery-Less Implantable CardioMEMS Sensor Device for Advanced Heart Failure Patients

Cardiologists at The Mount Sinai Hospital have begun implanting tiny, state-of-the-art microchip sensors in patients with advanced heart failure to better monitor symptoms and reduce their chances of returning to the hospital.

12 Jun 2015

Nanomedicine News

Chemists Witness Atoms of One Chemical Element Morph Into Another

Viscosizer TD from Malvern Instruments: A New Automated Tool for Biophysical Characterization

Novel Nanoplatform Technology to Detect Cancer Cells and Tumors in Early Stages

Scientists Successfully Characterize Molecular Structure of Small Heat Shock Protein

TechConnect 2015: Lehigh to Present Nanoscale Device to Capture Tumor Cells

Trojan Horse Nanoparticles Release Payload to Turn Off XBP1 Gene to Treat Ovarian Tumors

BIND and Macrophage Therapeutics Collaborate to Engineer Accurins with Manocept Targeting Platform

Arcturus, Janssen Collaborate to Commercialize RNA-Based Drugs Using Nanoparticle Delivery Platform

Merrimack Expands Phase 1 Study of Iron Oxide Nanoparticle Marker for nal-IRI Tumor Response Prediction

Battery-Less Implantable CardioMEMS Sensor Device for Advanced Heart Failure Patients

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials